CBSET PUBLICATIONS
2010
- Baker A, Chatzizisis Y, Beigel R, Jonas M, Stone B, Coskun A, Maynard C, Rogers C, Koskinas K, Feldman C, Stone P, Edelman ER. Regulation of heparanase expression in coronary artery disease in diabetic hyperlipidemic swine. Atherosclerosis 2010 Dec; 213(2):436-442.
- Balcells M, Martorell J, Olive C, Santacana M, Chitalia V, Cardoso A, Edelman ER. . Smooth muscle cells orchestrate the endothelial cell response to flow and injury. Circulation 2010 May; 121(20): 2192-9.
- Tzafriri A, Vukmirovic N, Kolachalama V, Astafieve I, Edelman ER. Lesion complexity determines arterial drug distribution after local drug delivery. Journal of Controlled Release 2010 Mar;142(3): 332-338.
2009
-
Kolachalama VB, Levine EG, Edelman ER. Luminal flow amplifies stent-based drug deposition in arterial bifurcations. PloS ONE 2009 Dec; 4(12): e8105.
- Tzafriri AR, Levin AD, Edelman ER. Diffusion-limited binding explains binary dose response for local arterial and tumor drug delivery. Cell Proliferation 2009 Jun; 42(3):348-363.
- Baker AB, Groothuis A, Jonas M, Ettenson DS, Shazly T, Zcharia E, Vlodavsky I, Seifert P, Edelman ER. Heparanase alters arterial structure, mechanics, and repair following endovascular stenting in mice. Circulation Research 2009 Feb;104(3):380-387
-
Kolachalama VB, Tzafriri AR, Arifin DY, Edelman ER. Luminal flow patterns dictate arterial drug deposition in stent-based delivery. Journal of Controlled Release 2009 Jan; 133(1):24-30.
-
Le KN, Hwang CW, Tzafriri A, Lovich MA, Hayward A, Edelman ER. Vascular regeneration by local growth factor release is self-limited by microvascular clearance. Circulation 2009;119(22):2928-2935.
2008
2007
2005
- M Jonas M, Edelman ER, Groothuis A, Baker AB, Seifert P, Rogers C. Vascular neointimal formation and signaling pathway activation in response to stent injury in insulin-resistant and diabetic animals. Circ Res 2005 Sep 30;97(7):725-33. Epub 2005 Aug 25
- Methe H, Nugent HM, Groothuis A, Seifert P, Sayegh MH, Edelman, ER. Matrix Embedding Alters the Immune Response Against Endothelial Cells In Vitro and In Vivo. Circulation 2005 Aug 30;112:189-195.
-
Balakrishnan B, Tzafriri AR, Seifert P, Groothuis A, Rogers C, Edelman ER. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents. Circulation 2005 Jun 7;111(22):2958-65.
-
Hwang CW, Levin AD, Jonas M, Li PH, Edelman ER. Thrombosis modulates arterial drug distribution for drug-eluting stents. Circulation 2005 Apr 5;111(13):1619-26.
-
Levin AD, Jonas M, Hwang CW, Edelman ER. Local and systematic drug competition in drug-eluting stent tissue deposition properties. Journal of Controlled Release 2005 Aug 15;109:236-243.
-
Tzafriri AR et al. Mathematical modeling and optimization of drug delivery from intratumorally injected microspheres. Clinical Cancer Research. 2005 11: 826-834.
2004
-
Levin AD, Vukmirovic N, Hwang CW, Edelman ER. Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. PNAS. 2004 Jun 22;101(25):9463-7.
2003
- Danenberg HD, Golomb G, Groothuis A, Gao J, Epstein H, Swaminathan RV, Seifert P, Edelman ER. Liposomal Alendronate Inhibits Systemic Innate Immunity and Reduces In-Stent NeointimalHyperplasia in Rabbits. Circulation. 2003 Dec 2; 108(22):2798-2804.
-
Janicki C, Hwang CW, Edelman ER. Dose model for stent-based delivery of a radioactive compound for the treatment of restenosis in coronary arteries. Medical Physics. 2003 Oct; 30(10): 2622-2628.
- Danenberg HD, Szalai AJ, Swaminathan RV, Peng L, Chen Z, Seifert P, Fay WP, Simon DI, Edelman ER. Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation. 2003 Aug 5;108(5):512-5
- Welt FG, Tso C, Edelman ER, Kjelsberg MA, Paolini JF, Seifert P, Rogers C. Leukocyte recruitment and expression of chemokines following different forms of vascular injury. Vascular Medicine. 2003;8(1):17.
2002
2001
2000
-
Drachman DE, Edelman ER, Seifert P, Groothuis AR, Bornstein DA, Kamath KR, Palasis M, Yang D, Nott SH, Rogers C. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. JACC. 2000 Dec;36(7): 2325-2332.
- Drachman DE, Edelman ER, Seifert P, Groothuis AR, Bornstein DA, Kamath KR, Palasis M, Yang D, Nott SH, Rogers C. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. Journal of the American College of Cardiology. 2000 Dec;36(7): 2325-2332.
-
Elmalak O, Lovich MA, Edelman E. Correlation of transarterial transport of various dextrans with their physicochemical properties. Biomaterials. 2000 Nov; 21(22): 2263-2272.
- Tavakkolizadeh A, Shen R, Abraham P, Kormi N, Seifert P, Edelman ER, Jacobs DO, Zinner MJ, Ashley SW, Whang EE. Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis. Journal of Surgical Research. 2000 Jun; 91(1): 77-82.
- Creel CJ, Lovich MA, Edelman ER. Arterial paclitaxel distribution and deposition. Circulation Research. 2000 Apr;86(8):879-884.
- Garasic JM, Edelman ER, Squire JC, Seifert P, Williams MS, Rogers C. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation. 2000 Feb;101(7): 812-8.
- Simon DI, Dhen Z, Seifert P, Edelman ER, Ballantyne CM, Rogers C. Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty. Journal of Clinical Investigation. 2000 Feb;105(3): 293-300.
-
Noh I, Lovich MA, Edelman ER. Mechanisms of heparin transport through expanded poly(tetrafluoroethylene) vascular grafts. J Biomed Mater Res. 2000 Jan;49(1): 112-9.
-
Tzafriri, AR. Mathematical modeling of diffusion-mediated release from bulk degrading matrices. Journal of Controlled Release. 2000 Jan 3;63(1-2):69-79.